|
82
|
241
|
7rnmA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with 2-(2-chloro-5-phenylthieno[2,3-d]pyrimidin-4-yl)isoindolin-5-ol and grip peptide |
|
2
|
8
|
7rnmC |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with 2-(2-chloro-5-phenylthieno[2,3-d]pyrimidin-4-yl)isoindolin-5-ol and grip peptide |
|
2
|
10
|
7nfbC |
Er-prs*(+) (y537s) in complex with genistein and src-2 coactivator peptide |
|
96
|
244
|
7nelA |
Er-prs*(+) (y537s) in complex with estradiol and src-2 coactivator peptide |
|
97
|
243
|
7nfbA |
Er-prs*(+) (y537s) in complex with genistein and src-2 coactivator peptide |
|
87
|
237
|
7ndoA |
Er-prs*(-) (l536s, l372r) in complex with raloxifene |
|
2
|
12
|
7nelC |
Er-prs*(+) (y537s) in complex with estradiol and src-2 coactivator peptide |
|
85
|
239
|
7rs8A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-16 |
|
88
|
249
|
7rs7A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-30 |
|
88
|
240
|
7rrxA |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-19 |
|
88
|
252
|
7rs2A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-23 |
|
91
|
247
|
7rs4A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-8 |
|
91
|
242
|
7rs0A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-18 |
|
87
|
242
|
7rs3A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-29 |
|
85
|
241
|
7rrzA |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-30 |
|
90
|
243
|
7rs9A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-25 |
|
88
|
244
|
7rryA |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-20 |
|
84
|
240
|
7rs8D |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-16 |
|
86
|
242
|
7rs1A |
Crystal structure of the er-alpha ligand-binding domain (l372s, l536s) in complex with dmeri-21 |
|
79
|
240
|
7msaA |
Gdc-9545 in complex with estrogen receptor alpha |
|
87
|
244
|
7kcaA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with raloxifene |
|
89
|
244
|
7kcdA |
Estrogen receptor alpha ligand binding domain in complex with a methylated lasofoxifene derivative that increases receptor resonance time in the nucleus of breast cancer cells |
|
91
|
244
|
7kbsA |
Estrogen receptor alpha ligand binding domain in complex with raloxifene |
|
2
|
8
|
7jhdC |
Estrogen receptor alpha ligand binding domain y537s in complex with ttc-352 and grip peptide |
|
89
|
242
|
7jhdA |
Estrogen receptor alpha ligand binding domain y537s in complex with ttc-352 and grip peptide |
|
83
|
250
|
6zosA |
Oestrogen receptor ligand binding domain in complex with compound 18 |
|
83
|
250
|
6zoqA |
Oestrogen receptor ligand binding domain in complex with compound 16 |
|
82
|
250
|
6zorA |
Oestrogen receptor ligand binding domain in complex with compound 28 |
|
86
|
239
|
6vpfA |
Estrogen receptor alpha ligand binding domain in complex with the selective estrogen receptor modulator clomiphene |
|
84
|
240
|
6wokA |
Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 |
|
73
|
242
|
6vvpA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with a methylated lasofoxifene derivative that possesses selective estrogen receptor degrader activities |
|
86
|
244
|
6vpkA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time |
|
84
|
242
|
6vj1A |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with ru39411 |
|
89
|
242
|
6vjdA |
Estrogen receptor alpha ligand binding domain in complex with lasofoxifene |
|
80
|
244
|
6vghA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with lasofoxifene |
|
90
|
244
|
6vnnA |
Estrogen receptor alpha ligand binding domain in complex with a methylated lasofoxifene derivative that increases receptor resonance time in the nucleus of breast cancer cells |
|
92
|
244
|
6vmuA |
Estrogen receptor alpha ligand binding domain in complex with a methylated lasofoxifene derivative with selective estrogen receptor degrader properties |
|
90
|
242
|
6vigA |
Estrogen receptor alpha ligand binding domain in complex with ru39411 |
|
76
|
240
|
6v8tA |
Estrogen receptor alpha ligand binding domain y537s in complex with lsz102 |
|
74
|
237
|
6v87A |
Estrogen receptor alpha ligand binding domain y537s in complex with 4-hydroxytamoxifen |
|
89
|
245
|
6sboA |
Estrogen receptor mutant l536s |
|
90
|
244
|
6psjA |
Bazedoxifene in complex with y537s estrogen receptor alpha ligand binding domain |
|
85
|
250
|
6sq0A |
Era_l536s (l536s/c381s/c471s,c530s) in complex with a bridged tetracyclic indole (compound 8) |
|
84
|
250
|
6suoA |
Era_l536s (l536s/c381s/c471s,c530s) in complex with a tricyclic indole (compound 6) |
|
87
|
241
|
6pitA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with src2 stapled peptide 41a and estradiol |
|
82
|
240
|
6pitB |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with src2 stapled peptide 41a and estradiol |
|
82
|
224
|
6pfmA |
Crystal structure of gdc-0927 bound to estrogen receptor alpha |
|
78
|
240
|
6petA |
Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha |
|
13
|
71
|
4aa6A |
The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation |
|
83
|
237
|
6iarA |
Tricyclic indazoles a novel class of selective estrogen receptor degrader antagonists |
